As of May 29, 2025, FSD Pharma Inc (HUGE.CN) reports a Current Ratio of 2.28.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of FSD Pharma Inc's Current Ratio
Over recent years, FSD Pharma Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2021-12-31 | 2.28 |
| 2020-12-31 | 4.82 |
| 2019-12-31 | 1.25 |
| 2018-12-31 | 12.94 |
| 2017-12-31 | 4.26 |
This slight upward trend highlights how FSD Pharma Inc manages its short-term assets and liabilities over time.
Comparing FSD Pharma Inc's Current Ratio to Peers
To better understand FSD Pharma Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| FSD Pharma Inc (HUGE.CN) | 2.28 |
| Titan Pharmaceuticals Inc (TTNP) | 6.08 |
| Skye Life Ventures Ltd (SKLV) | 4.98 |
| Cocrystal Pharma Inc (COCP) | 4.77 |
| 48North Cannabis Corp (NRTH.V) | 3.96 |
| Avenue Therapeutics Inc (ATXI) | 3.27 |
Compared to its competitors, FSD Pharma Inc's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.